Laronidase - BioMarin/Sanofi
At a glance
- Drug Originator BioMarin Pharmaceutical; Genzyme Corporation
- Drug Class Glycoside hydrolases; Recombinant fusion proteins
- Mechanism of Action Iduronidase replacements
- USA Patent Applicants BIOMARIN
- USA Patents 28
- BLAs 1
- International Patents 344

Disclaimer